Rare cancers are not rare in Asia as well: The rare cancer burden in East Asia.

[1]  G. Ursin.  Cancer registration in the era of modern oncology and GDPR , 2019, Acta oncologica.

[2]  Wen-Chung Lee,et al.  Taiwan's Nationwide Cancer Registry System of 40 years: Past, present, and future. , 2019, Journal of the Formosan Medical Association = Taiwan yi zhi.

[3]  J. Blay,et al.  Networking in rare cancers: What was done, what's next. , 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[4]  T. Hsia,et al.  Interleukin-18 promoter genotype is associated with the risk of nasopharyngeal carcinoma in Taiwan , 2018, Cancer management and research.

[5]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[6]  J. Lagergren,et al.  Global time trends in the incidence of esophageal squamous cell carcinoma , 2018, Clinical epidemiology.

[7]  K. Yonemori,et al.  MASTER KEY project: A basket/umbrella trial for rare cancers in Japan. , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

[8]  T. Shibata,et al.  Current state of therapeutic development for rare cancers in Japan, and proposals for improvement , 2018, Cancer science.

[9]  Eva Ardanaz,et al.  Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet-a population-based study. , 2017, The Lancet. Oncology.

[10]  Eva Steliarova-Foucher,et al.  International incidence of childhood cancer, 2001–10: a population-based registry study , 2017, The Lancet. Oncology.

[11]  Eva Ardanaz,et al.  Data Quality in Rare Cancers Registration: The Report of the RARECARE Data Quality Study , 2017, Tumori.

[12]  T. Burki.  Unnecessary thyroid cancer screening in South Korea. , 2017, The Lancet. Oncology.

[13]  Ching-Lung Lai,et al.  Epidemiology of Hepatocellular Carcinoma in the Asia-Pacific Region , 2016, Gut and liver.

[14]  Jeffrey S. Chang,et al.  Incidence trends of human papillomavirus‐related head and neck cancer in Taiwan, 1995–2009 , 2015, International journal of cancer.

[15]  J. Sohn,et al.  Diagnostic Coding for Intramucosal Carcinoma and Neuroendocrine Tumor in the Colorectum: Proposal for Avoiding Confusing Coding in Korea , 2015, Clinical endoscopy.

[16]  M. Lai,et al.  Quality assessment and improvement of nationwide cancer registration system in Taiwan: a review. , 2015, Japanese journal of clinical oncology.

[17]  T. Sobue,et al.  Recent trends in population-based cancer registries in Japan: the Act on Promotion of Cancer Registries and drastic changes in the historical registry , 2015, International Journal of Clinical Oncology.

[18]  Y. Ohno,et al.  The burden of rare cancer in Japan: application of the RARECARE definition. , 2014, Cancer epidemiology.

[19]  S. Tsao,et al.  Etiological factors of nasopharyngeal carcinoma. , 2014, Oral oncology.

[20]  Y. Qiao,et al.  Managing the changing burden of cancer in Asia , 2014, BMC Medicine.

[21]  R. Jensen,et al.  Epidemiological trends of pancreatic and gastrointestinal neuroendocrine tumors in Japan: a nationwide survey analysis , 2014, Journal of Gastroenterology.

[22]  Chun‐Chieh Wu,et al.  The Epidemiology of Neuroendocrine Tumors in Taiwan: A Nation-Wide Cancer Registry-Based Study , 2013, PloS one.

[23]  Jae Hyuk Lee,et al.  Current Trends of the Incidence and Pathological Diagnosis of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) in Korea 2000-2009: Multicenter Study , 2012, Cancer research and treatment : official journal of Korean Cancer Association.

[24]  G. Gatta,et al.  Rare cancers are not so rare: the rare cancer burden in Europe. , 2011, European journal of cancer.

[25]  Chien-Jen Chen,et al.  Independent Effect of EBV and Cigarette Smoking on Nasopharyngeal Carcinoma: A 20-Year Follow-Up Study on 9,622 Males without Family History in Taiwan , 2009, Cancer Epidemiology Biomarkers & Prevention.

[26]  C. la Vecchia,et al.  Gallbladder cancer worldwide: Geographical distribution and risk factors , 2006, International journal of cancer.

[27]  P. Pisani,et al.  Nationwide cancer incidence in Korea, 1999~2001; first result using the national cancer incidence database. , 2005, Cancer research and treatment : official journal of Korean Cancer Association.

[28]  Yaoh-Shiang Lin,et al.  Epidemiology of Oral Cavity Cancer in Taiwan with Emphasis on the Role of Betel Nut Chewing , 2005, ORL.

[29]  Chien-Jen Chen,et al.  Evaluation of Risk Factors for Nasopharyngeal Carcinoma in High-Risk Nasopharyngeal Carcinoma Families in Taiwan , 2005, Cancer Epidemiology Biomarkers & Prevention.

[30]  Iarc Monographs,et al.  Betel-quid and areca-nut chewing and some areca-nut derived nitrosamines. , 2004, IARC monographs on the evaluation of carcinogenic risks to humans.